Yes — PMOS (Polyendocrine Metabolic Ovarian Syndrome) is the updated medical name for what was previously called PCOS. The international medical community renamed it in 2026 to better reflect that it's a hormonal and metabolic condition, not one defined by ovarian cysts. If you've been diagnosed with PCOS, this is the same condition.

Yes — insulin resistance is common with PMOS and makes weight gain more likely and weight loss harder. GLP-1 medication can be integrated directly into your PMOS treatment plan when clinically appropriate, managed by the same endocrinologist overseeing your hormonal care.

Yes, in most cases — hormone panel testing, metabolic markers, and consultations are typically covered. We'll confirm your exact coverage before your visit.

No — while risk increases with age and after menopause, low testosterone in men and perimenopausal hormone changes in women can affect bone health earlier than most people expect. Our Bone Mineral Density scan can identify risk before it becomes a fracture concern.

Published research shows HRT can meaningfully reduce cardiovascular disease risk, improve mood and sleep disturbances, and improve bone density — it's not just about symptom relief.